A patient with end stage heart failure underwent permanent implantation of a Novacor left ventricular assist system. Progressive right ventricular dysfunction developed during the first two postoperative weeks. Temporary and subsequently permanent atrioventricular pacing to correct first degree heart block improved the performance of the device, with sustained resolution of his right ventricular failure. (Heart 1996;75:525-527) Keywords: assist system; first degree heart block; right ventricular failure; atrioventricular pacing It was noted that shortening the AV interval, without changing the heart rate, had a beneficial effect on LVAS function. Thus during sinus rhythm at 102 beats/min, with a PR interval of 220 ms, the peak fill rate was 190 ml/min and the pump output was 5 3 I/min. Atrial tracking and ventricular pacing at the same sinus rate with an AV interval of 100 ms increased these variables to 230 ml/min and 6X2 I/min respectively. A Medtronics Thera-D dual chamber pacemaker was therefore inserted three weeks after LVAS implantation. Haemodynamic variables during various pacing modes were recorded in the pacing laboratory, with the patient supine and at 300 feet-down tilt to alter venous return. Figure 1 shows how shortening the AV interval enhanced LVAS (and hence right ventricular) performance. This electrophysiological manoeuvre also decreased the systolic wave on the right atrial pressure trace (fig 2) . On the basis of these data, the pacemaker was programmed to DDD mode with a base rate of 90 beats/min 525
The Novacor left ventricular assist system (LVAS) is an electrically driven implantable blood pump designed to work in parallel with the left ventricle, taking blood from the apex of the left ventricle and delivering it to the ascending aorta. ' The output of the device depends primarily on filling, which in turn is dependent upon delivery from the right side of the circulation, together with active filling from the native left ventricle. With a stroke volume of 70 ml, the device is capable of total left ventricular unloading. Peak It was noted that shortening the AV interval, without changing the heart rate, had a beneficial effect on LVAS function. Thus during sinus rhythm at 102 beats/min, with a PR interval of 220 ms, the peak fill rate was 190 ml/min and the pump output was 5 3 I/min. Atrial tracking and ventricular pacing at the same sinus rate with an AV interval of 100 ms increased these variables to 230 ml/min and 6X2 I/min respectively. A Medtronics Thera-D dual chamber pacemaker was therefore inserted three weeks after LVAS implantation. Haemodynamic variables during various pacing modes were recorded in the pacing laboratory, with the patient supine and at 300 feet-down tilt to alter venous return. Figure 1 shows how shortening the AV interval enhanced LVAS (and hence right ventricular) performance. This electrophysiological manoeuvre also decreased the systolic wave on the right atrial pressure trace (fig 2) . On the basis of these data, the pacemaker was programmed to DDD mode with a base rate of 90 beats/min and an AV interval (paced and sensed) of 120 ms.
The patient progressed well with no signs of heart failure on no diuretic therapy. At the time of discharge from hospital, six weeks after LVAS implantation, the beneficial haemodynamic effect of reducing the AV interval was again demonstrated. On this occasion, transthoracic echocardiographic colour Doppler mapping suggested a decrease in the magnitude of the tricuspid regurgitant jet during the transition from sinus rhythm to atrial tracking.
Discussion
First degree heart block is a common, benign conduction defect that usually has no overt haemodynamic consequences, even in patients with severe heart disease. In this patient, however, the use of DDD pacing to correct first degree block had a beneficial effect on haemodynamic indices of right ventricular performance, as reflected by the filling characteristics and output of the LVAS, and contributed to the resolution of right ventricular failure after LVAS implantation.
In most patients, pulmonary vascular resistance decreases and systemic venous return increases after LVAS implantation, with an improvement in right ventricular function.' However, acute right ventricular failure occurs in about 20% of patients,3 although the insidious onset observed in our patient was unusual. 
